Chapter 3: Gene expression (lecture 2) Flashcards

1
Q

Thus far we discussed 1) Transcription 2) Chromatin structure And we’re going to look into these topics now: 3) DNAmethylation 4) microRNAs (miRNAs) 5) Telomeres and telomerase 6) Therapeutic options

A

okay good to know

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

DNA methylation is an epigenetic modification to the DNA. Which enzyme is involved in this proces?

A

DNA methyltransferases (DNMT’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

There are two types of DNA methyltransferases. What are they and where are they used?

A
  • De novo methyltransferases recognize something in the DNA that allows them to newly methylate cytosines. These are expressed mainly in early embryo development and they set up the pattern of methylation.
  • Maintenance methyltransferases add methylation to DNA when one strand is already methylated. These work throughout the life of the organism to maintain the methylation pattern that had been established by the de novo methyltransferases.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

On what sequence does methylation occur?

A

On Cs preceding a G (CpG)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Are CpG’s under- or overrepresented in DNA?

A

Underrepresented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why are CpG’s underrepresented in the DNA?

A

This underrepresentation is a consequence of the high mutation rate of methylated CpG sites: the spontaneously occurring deamination of a methylated cytosine results in a thymine, and the resulting G:T mismatched bases are often improperly resolved to A:T; whereas the deamination of thymine results in a uracil, which as a foreign base is quickly replaced by a cytosine by the base excision repair mechanism. The C to T transition rate at methylated CpG sites is ~10 fold higher than at unmethylated sites.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Where are clusters of CpGs (CpG islands) often found?

A

In gene promoters (about 50% of genes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Fill in: DNA methylation … transcription

A

Inhibits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does DNA methylation inhibit transcription?

A
  1. Binding of proteins that recognize methylated CpG DNA
    1. prevent binding of TFs
    2. recruit HDACs (eg. MeCP1,2)
      1. Remember that HDACs enforce compression/packaging of the DNA
  2. Direct interference with binding of TFs
  3. Compression of the DNA (packaging)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The cooperation in epigenetics is also depicted in the following figure

A

Note how the recruitment of HDAC (instead of HAT) results in the packaging of the DNA. This is all under influence of the methylation (red small circles)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Tumors make use of the effects of DNA methylation. Do they do this by hypermethylation or hypomethylation? Is this done for onco- or suppressor genes?

A

hypermethylation (on promoters) that silences tumor suppressor genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Interesting enough, tumors globally hypomethylate. What does this lead to?

A

Re-expression of silenced genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why is the hypermethylation of suppressor genes and the hypomethylation of silenced genes beneficial for a tumor cell?

A

So it can grow fasters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Sodium bisulfite can be used to detect DNA methylation. How is this seen?

A

Sodium bisulfite specifically deaminates CpG’s that are not methylated. The unmethylated CpG’s will be mutated from C -> U, whereas methylated DNA is protected from this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the easiest method to see the effects of sodium bisulfite (aka see which sequences are methylated)?

A

Read-out by sequencing, a T will be formed instead of a C, as can be seen by the arrows in the figure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Besides read-out sequencing, read-out by PCR can also be used to detect methylated sites. How does this work?

A

Primers are used that specifically detect either the methylated or unmethylated strand of DNA (the difference of course is the C/T). An example of this is shown in the figure, where can be seen that the cancer cells have highly regulated the mir-3663 promoter.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are micro RNAs (miRNAs)?

A

Very small (~22 nucleotides) non-coding RNA molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

True/false: Transcription of miRNA genes is regulated by the same (epi)genetic mechanisms as protein-coding genes

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the function of miRNA? How?

A

post-transcriptional regulation of gene expression

1) Repression of translation (imperfect match)
2) mRNA destabilisation or cleavage (perfect match)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

There can be deregulated expression of miRNA in cancer. Where are miRNAs often downregulated, and where are miRNAs often upregulated?

A

Downregulated miRNA: oncogene (resulting in more protein)

Upregulated miRNA: suppressor gene (resulting in less protein)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How are miRNAs processed right after they’re made by the DNA polymerase?

A

They are taken up and cleaved by the DGCRB/DROSHA (don’t remember this name) to form a hair-pin like structure. They are then transported outside the nucleus where a DICER will cleave the ‘head’ off, creating a mature miRNA. This can then be taken up by a RISC protein to fulfill its function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which side of the miRNA specifically reacts with which side of an RNA?

A

The 5’ end of the miRNA often reacts with the 3’ (UTR) of the RNA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

True/false: There are many-to-many interactions between microRNA:messengerRNA

A

True. Many microRNAs can interact with different messengerRNAs and vice versa, which creates a broad spectrum of regulation

24
Q

In cancer, is there a general reduction or increase of miRNA? What is this a result of?

A

There is a reduction, this is due to lower DICER (remember, this was an enzyme that cleaves the miRNA to make it functional)

25
Q

miRNAs can be used as a biomarker. In what type of cancer can they be used in this way?

A

Cervical cancer

26
Q

A study by Wilting et al showed in 2013 the expression of miRNA in cervical cancer. What did they find?

A
  • miR-9: increased expression due to 1q gain (Wilting et al, Oncogene 2013)
  • miR-203: decreased expression due to methylation (Wilting et al, Epigenetics 2013)
27
Q

Earlier we saw that there can be an increased or decreased expression of miRNA in cervical cancer. What conclusion can be drawn, when looking at this figure? Slide 41

A

That especially the ratio between the two is a good indicator for the prediction of malignancy in a cell

28
Q

What are long non-coding RNAs?

A

As the name suggests, long non-coding RNAs are a type of RNA, defined as being transcripts with lengths exceeding 200 nucleotides that are not translated into protein.

29
Q

True/false: long non-coding RNAs are initially processed the same as coding RNA

A

True

30
Q

What is the function of long non-coding RNAs?

A

The range of functions is very wide, it does not fall into a category.

For example:

  • Some function in nucleus (Xist, HOTAIR, TERRA)
  • Some pseudogenes may function as “decoys” for miRNA repression of coding counterpart (e.g. PTENP1/PTEN)
31
Q

Long non-coding RNAs can also be used as a potential biomarker. What is an example of this?

A

PCA3 for prostate cancer (actually works better than PSA, which is used currently)

32
Q

An example that was given for a long non-coding RNA was the Xist. This is quite an important molecule. Why?

A

It is a X-inactive specific transcript (Xist) on the X chromosome that plays a role in the X-inactivation process

33
Q

Another example that was given for long non-coding RNA is the pseudogene of PTENP1/PTEN. Explain how this plays a role in cancer

A

PTENP1/PTEN is a tumor suppressor gene, of which the pseudogene is very similar to the actual gene (but not transcribed). They found that this pseudogene stimulates the expression of the tumor suppressor gene. You can imagine that if this pseudogene is lost (e.g. in cancer cells), there is repression of the suppressor gene.

34
Q

We will now go into the subject of telomeres. Please note that this has nothing to do with DNA regulation

A

The lecturer thinks this topic did not fit in any other chapter, so that’s why it’s discussed here

35
Q

What are telomeres?

A

Repeats (several 1000) at the end of chromosomes (TTAGGG)

36
Q

Fill in: Telomeres end in a 3’ single strand overhang, which form a … to avoid being seen as DNA breaks.

A

T-loop

37
Q

What complex maintains the stability of the T-loop?

A

Shelterin

38
Q

What enzyme ensures the extension of telomerase? What type of enzyme is this?

A

Telomerase, this is a reverse transcriptase (so translates RNA to DNA)

39
Q

Of what two components does the telomerase exist?

A

hTERT (enzyme) and hTR (RNA template)

40
Q

True/false: Telomere is expressed in all cells

A

False, telomere is only expressed in (embryonic) stem cells and germ line cells

41
Q

How can telemores be shortened (2 ways)?

A
  1. The ‘end replication problem’ (I will not go in depth about this)
  2. Oxidative stress (because there is no repair mechanism)

If you do not understand why there is an end replication problem, please see slide 46-48, but I deem this basic knowledge…

42
Q

Because telomerase is not expressed in normal cells, every cell division there are base pairs that are lost. Explain at which rate this goes. (for illustration)

A

After each cell division 100-200 base pairs are lost at the telomere. After 50-100 cell devisions there is a critically short telomere, that is picked up by the cell.

43
Q

Illustrate how the telemore extension looks per cell type over a period of time (e.g. germ line, stem cells, normal cells)

A

Don’t learn this by heart but understand the concept

senescence = cell rest, will not divide anymore

44
Q

Where in the gene of telomerase are often hotspots for cancer mutations found?

A

In the promoter of TERT (the enzyme part)

45
Q

What type of mutation is found in the promoter of TERT?

A

A deamination change, so a C is changed to a T

46
Q

What does the mutation on the TERT lead to?

A

A binding site for a TF, so the expression of telomerase is activated

47
Q

How common is the mutation in the promoter of TERT?

A

Very common (>50% of patients) in various cancer types (melanoma, bladder- and thyroid cancer)

48
Q

In how many % of the cancer is the telomerase reactivated?

A

90%!

49
Q

You would think that telomerase is the perfect cancer treatment target. This is not the case. Why?

A
  1. Inhibitors struggled to due to bioavailability (not picked up by cells) and toxicity
  2. Cancers may have already produced many cells with relatively long telomers
  3. Resistance
50
Q

Fill in: We see that in cancer transcription is heavily … due to (epi)genetic changes

A

deregulated

51
Q

What are therapeutic options that target the epigenetic changes?

A
  1. DNA methylation inhibitors + HDAC inhibitors: reactivation of silenced genes (tumor suppressors)
  2. Telomerase inhibitors: restore mortality of cancer cells
52
Q

Why do we want to use DNA methylation inhibitors? Aren’t the cancer cells already heavily hypomethylated?

A

Because then the silenced genes might be reactivated, resulting in some control back in the cell. However, this is aspecific, so you have to make sure the cancer you treat is sensitive to this treatment.

53
Q

Cancer-specific epigenetic changes can also be used for something else than treatment. What are they?

A

Screening, diagnosis and prognosis (examples of this we already discussed)

54
Q

Exam question: Transcription factors are proteins consisting of multiple domains each with a specific function. Which of the following is TRUE:

A) All transcription factors contain a DNA-binding domain

B) All transcription factors contain a ligand-binding domain

C) All transcription factors contain a dimerization domain

D) None of the above

A

A) All transcription factors contain a DNA-binding domain

55
Q

Other exam questions you can think about but that were not discussed in the lecture:

A
  1. Transcription factors are proteins that can bind to promoter regions of genes and in this way control its expression. To this end transcription factors contain domains with specific functions. Name two of these domains and explain their function.
  2. Promoter regions of genes can contain so-called CpG islands: sequences that are enriched for CpG dinucleotides. The C residues of these dinucleotides can be methylated by DNA methyl transferases. Does this methylation contribute to activating transcription or silencing of the respective gene?
  3. Some genes have undergone epigenetic alterations in tumors. What does this mean?